PATENT CLAIM ANALYSIS

Application Number: 15874758
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-01
Patent Classification: ["424", "186100"]

Abstract:
The present invention provides anti-hemagglutinin antibodies, compositions comprising anti-hemagglutinin antibodies, and methods of using the same.

Claim (Index 58):
The isolated nucleic acid of  claim 54 , wherein the antibody comprises a light chain comprising an amino acid sequence selected from the group consisting of SEQ ID NOs:112, 116, 118, 121, 123, 125, 127, 129, and 131.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 86.0
- Lexical Diversity: 1.1875
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14077414', '14275174', '14725508', '15042436', '14669317']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8461185532962976
- 35 USC 102 Novelty (BERT): 0.6793150339999446
- Combined Prediction Score: 0.8294382013666622
- Mean Citation Score: 755.57028
- Max Citation Score: 812.2035
- Similarity Product: 650.7688407742381

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test